[Is it permissible to treat young diabetics with oral antidiabetics?].
Authors analyzed the case history of 25 young diabetic patients, whose disease has been diagnosed before the age of thirty. The question that has been raised: is it allowed to treat young diabetics with oral drugs? By classifying the patients, they stated followings: In the 1. group they classified 16 verified MODY/NIDDY patients. In the second group they classified 3 young diabetics, whose disease had been evaluated as slowly progressing IDDM (autoimmune form). 3 patients belonged to the 3 group. They had been classified as MODY/NIDDY patients, however an extremely long lasting remission period--due to the short observation time--can not be excluded. The remaining 3 diabetic patients belonged to the IDDM group, with a long remission period. They were treated incorrectly with oral hypoglycemic drugs. Young diabetics can be treated with oral drugs only in case, when they are proven MODY/NIDDY patients. The precise differential diagnosis between this form and autoimmune IDDM, as well as long lasting remission periode, is extremely important.
Halmos
T
T
Országos Korányi Tbc és Pulmonologiai Intézet, Budapest.
Kautzky
L
L
Grósz
A
A
Pánczél
P
P
Gerö
L
L
Winkler
G
G
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001645:Biguanides / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004341:Drug Evaluation; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007231:Infant, Newborn; D008297:Male; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds
Szabad-e fiatal cukorbetegeket orális antidiabetikumokkal kezelni?